LeonaBio (LONA) Amortizatization of Intangibles (2019 - 2026)
LeonaBio's (LONA) quarterly Amortizatization of Intangibles came in at $260000.0 in Q1 2026, up 300.0% year-on-year from $65000.0 in Q1 2025, and up 288.06% on a QoQ basis from $67000.0 in Q4 2025.
LeonaBio (LONA) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Amortizatization of Intangibles data on file, last reported at $260000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 300.0% year-over-year to $260000.0 in Q1 2026; TTM through Mar 2026 was $524000.0, a 66.88% increase from a year earlier, with the FY2025 full-year figure at $329000.0, down 36.12% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $260000.0, up from $67000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for LONA reached as high as $406000.0 in Q2 2023 and fell as low as -$140000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $172941.2 across 5 years, with a median of $165000.0 in 2024.
- Across the five-year window, Amortizatization of Intangibles soared 4611.11% in 2023 and tumbled 90.46% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $355000.0 in 2022, then slipped by 20.28% to $283000.0 in 2023, then tumbled by 90.46% to $27000.0 in 2024, then jumped by 148.15% to $67000.0 in 2025, then jumped by 288.06% to $260000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $260000.0 in Q1 2026, $67000.0 in Q4 2025, and $70000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 260,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 260,000.00 |
| Mar 31, 2026 | 260,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | 283,000.00 |
| Dec 31, 2023 | 283,000.00 |